Fundz

Revolution Medicines, Inc. reported raising $100 Million in an initial SEC Form D filing, from an offering of $100 Million

PUBLIC · RVMDNov 15, 2019

Amount Raised

$100 Million

$100 Million sold, per SEC Form D (first sale Nov 15, 2019)

Round Type

Venture

Redwood CityBiotechnologyHealthcareHealth CareTherapeuticsPharmaceutical

Quick answer

Revolution Medicines raised $100 Million in a funding round, dated November 15, 2019. Revolution Medicines is based in Redwood City, California, United States.

How much did Revolution Medicines raise?
Revolution Medicines raised $100 Million in a funding round on November 15, 2019.
What does Revolution Medicines do?
Revolution Medicines, Inc. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers.
Where is Revolution Medicines based and how big is it?
Revolution Medicines is based in Redwood City, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Revolution Medicines that raised within 45 days of this round, from Fundz verified event records.

  • Zevra Therapeutics, Inc. raised $71M on December 23, 2019.
  • ISOThrive raised $4M on November 14, 2019.
  • vTv Therapeutics Inc. raised $2M (Seed) on October 15, 2019.
  • Kinnate Biopharma raised $74M on December 23, 2019.
  • Windtree Therapeutics raised $26M on December 19, 2019.
  • VistaGen raised $650K on December 12, 2019.

Who to call at Revolution Medicines, and when

A new round usually means Revolution Medicines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Revolution Medicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Revolution Medicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Revolution Medicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Revolution Medicines

Location

700 Saginaw Dr

Redwood City, California, United States

About

Revolution Medicines, Inc. Revolution Medicines is a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. The company’s RAS(ON) Inhibitors RMC-6236 (RASMULTI), RMC-6291(KRASG12C) and RMC-9805 (KRASG12D) are currently in clinical development. Additional RAS(ON) Inhibitors in the company’s pipeline include RMC-0708 (KRASQ61H) which is currently in IND-enabling development, RMC-8839 (KRASG13C), and additional compounds targeting other RAS variants. RAS Companion Inhibitors in clinical development include RMC-4630 (SHP2) and RMC-5552 (mTORC1/4EBP1).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Revolution Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Revolution Medicines's next move

See what Strategic adds

Revolution Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.